Introduction
Lobular intra-epithelial neoplasia (LIN), which comprises atypical lobular neoplasia and lobular carcinoma in situ, is a rare disease characterised by non invasive lobular breast proliferation [1] .
The incidence of LIN, has increased dramatically in recent years, at least partly due to the widespread uptake of mammographic screening [2] .
Since the first description of LIN in 1941 [3] , its treatment has remained controversial; ranging from simple biopsy [4, 5, 6, 7] to ipsilateral mastectomy and contralateral biopsy [8] , or even bilateral mastectomy [9] . The treatment choice has largely been dependent on the estimation of the invasive breast cancer risk and on whether LIN was considered as a marker of increased risk of cancer for both breasts (the "risk factor theory") [10] or a true breast cancer precursor (the "precursor theory") [11] .
This review addresses the evaluation of the risk of invasive breast cancer (IBC) and ductal carcinoma in situ (DCIS) following a diagnosis of LIN. It also examines whether the characteristics of the cancers diagnosed following LIN favour "the risk factor" or "the precursor" theory.
Methods
A PubMed search was carried out on January 31, 2010. The search strategy consisted of terms "lobular intra-epithelial neoplasia", "lobular carcinoma in situ", "atypical lobular hyperplasia", combined with "breast cancer", "breast carcinoma". The search was limited to articles published in English from 1969 to the search date and resulted in an output of 1761 articles. The available abstracts were reviewed for relevance to the topic of breast cancer risk of original series of patients after LIN diagnosis.
Since LIN was in most cases an incidental finding, it was often associated with various benign breast disease conditions that had led to the breast biopsy. However patients were only included when LIN was considered the most risk-associated pathological finding. Patients with associated DCIS and invasive breast cancers were excluded.
Where several articles referred to the same patient's series, only the last publication was taken into account. The 22 articles which met these criteria form the basis of this report.
The publications of Chuba et al [10] and Li et al [12] 
Results

Cumulative risk of breast cancer after LIN
For a women diagnosed with LIN, the cumulative average risk of metachronous breast cancer (IBC or DCIS) was 9.6% (range 0-32). The average risk of IBC was 8.7% (range 0-33) whereas the average risk of DCIS was 2.9% (range 0-13) ( Table 1 ).
The average risk for IBC for the ipsilateral breast was 4.7% (range 0-25) which was (although slightly greater) near the level of risk for the contralateral breast that was 4.2% (range 0-16).
The difference in risk between the two breasts was more pronounced for the risk of DCIS that M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 5 was 2.3% (range 0-10) for the ipsilateral breast and 0.9% (range 0-4) for the contralateral breast ( Table 2) .
Relative risk of invasive breast cancer after LIN
To answer the question whether LIN modifies the IBC risk in a woman it is necessary to compare the observed IBC incidence in LIN patients with that of the general population. Table 3 summarizes the studies, which compared the risk of IBC in LIN patients to the risk of a referent population. Only studies with available 95% confidence intervals are reported. The relative risk was calculated by the ratio of the IBC rates observed in the LIN patients to the expected rates if IBC incidence was the same in LIN patients as it is in the population at large.
The expected number of females developing IBC after LIN was calculated per year of diagnosis and age group [10, 13] . All studies were concordant to demonstrate an excess of IBC risk in LIN patients, with a relative risk ranging from 2.4 to 11.9.
Modifiers of invasive breast cancer risk after LIN
Various qualitative and quantitative pathological features were evaluated for association with IBC risk after LIN [4, 5, 7, 13, 14, 15, 16] . Higher IBC risk was only found to be associated with intense lymphocytic reaction in lobules with LIN [16] , larger nuclear size [4] , and pathological grade 3 or 2 according a three tired grading system [7] .
Age at LIN diagnosis also modified the IBC risk in the study by Bodian et al, with an increased risk for women younger than 40 years and a decreased risk for women older than 55 years [13] . However this result was not confirmed in other studies [10, 12, 17, 18] .
No association could be demonstrated between IBC risk after LIN and ethnicity, reproductive factors, or family history [10, 12, 13, 16] .
Characteristics of invasive breast cancers after LIN
Fifty-two percent of breast cancer (BC) occurred more than 10 years after the initial diagnosis of LIN was made (Table 4 ). Compared to ipsilateral BC, contralateral BC were more M A N U S C R I P T
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6 frequently delayed. Contralateral BC were less frequent during the first five years and more frequent after 10 years. Compared to the general population the relative risk of IBC in the LIN patients was not dependent on the follow-up [10, 12, 13, 15, 17, 18] . The excess of risk was almost identical up to 20 years after the LIN diagnosis [10, 13, 17] . Beyond twenty years of follow-up there were too few patients to provide valid estimations.
A lobular histotype was present in 30% (range 0 to 67) of all IBC recurrences (Table 1) . A lobular histotype was more frequent for ipsilateral IBC (51% range 0 -100) than for contralateral IBC (41% range 0 -60).
The topography of ipsilateral IBC recurrences were only reported in 3 studies. In the study by Carson et al, one out of three recurrences were in the same quadrant as the initial LIN [19] . In the study by Cutuli et al [20] , the sole ipsilateral recurrence was in the same quadrant as the initial LIN and in the series reported by Fisher et al, all the nine ipsilateral recurrences were in the same quadrant [7] .
Discussion
In this review the cumulative average risk of metachronous IBC was 8.7% but with a wide variation from study to study, ranging from 0 to 33%. The risk was slightly greater for the ipsilateral as compared to the contralateral breast. Tumors characteristics supported arguments both for considering LIN as a non obligatory breast cancer precursor and as a risk factor for bilateral breast cancer.
Before interpreting results of this study, it is important to acknowledge its limitations. Most of the follow-up studies of women with LIN are both small and retrospective. Studies have differed with respect to several factors including criteria for patient selection, length of follow-up, treatment of LIN and periods of inclusion (spanning from 1940 [21] to 2002 [12] ).
Histological diagnoses were oftently made by community pathologists at different periods of
time, misclassification of histologic types is likely to have occurred. DCIS following LIN were inconsistently reported [14, 17, 10, 12] , and in some series it was not possible to distinguish DCIS and IBC [13] . We only recorded metachronous breast cancers, however the definition differed slightly from study to study using the term metachronous to define breast cancers occurring either more than 6 or 12 months after the initial LIN diagnosis [7, 12] .
Another limitation of the current study was the impossibility due to the study design to control for the confounding factors in the estimation of IBC risk, particularly the length of follow-up and the initial treatment of the LIN.
However, the greatest limitation of the LIN series that form the basis of our review is the rarity of the disease. In our study the estimations of IBC risk are based on more than 6000 patients diagnosed with LIN. When Foote and Stewart described LIN it was viewed as a malignancy requiring a mastectomy [3] . However, retrospective studies of archived breast biopsy specimens originally read as benign and diagnosed as LIN on review showed that most women had not developed breast cancer even after long follow-up and that invasive breast cancer did not necessarily arise in the breast where the LIN was initially diagnosed [15] . This results were confirmed by series of patients treated with excisional biopsy alone. In those series the 20 years cumulative risk was up to 33%, and women with LIN were equally likely to be diagnosed with ipsilateral and contralateral invasive breast cancers [14, 15, 16, 22] . The LIN was then considered as a marker of breast cancer risk. The only logical approaches under this "risk factor theory" were either a close follow-up or a bilateral mastectomy. However, bilateral mastectomy was unnecessary for the vast majority of patients, and this procedure never achieved great popularity even by the time when conservative procedures were developed for IBC [23] .
More recently the "precursor theory" has gained popularity since it was demonstrated that LIN and invasive lobular neoplasia share the lack of expression of the E-cadherin adhesion cell molecule. This latter finding suggests a possible transformation of LIN into invasive lobular neoplasia [11] .
In our study the relatively low level of risk for invasive breast cancer and the time distribution of the recurrences with more than 50% of BC occurring more than 10 years after the initial LIN were in favour of the risk factor theory. Another major argument was the risk of invasive contralateral breast cancer that was near the level of risk for ipsilateral invasive breast cancer.
Some authors have argued that contralateral breast cancers risk was explained by the frequent bilaterality of LN. However, similar levels of risk were observed in series were contralateral breast biopsies were systematically performed at the time of the LIN diagnosis [8] . Another argument for the "risk factor theory" was that the majority of IBC following LIN do not contain any invasive lobular histotype (Table 1) .
On the other hand some results of our study clearly advocate the precursor theory. Although the average level of IBC risk was low, there was a wide range in the risk between studies. The highest risks were observed in studies where no surgical procedure other than the initial excision biopsy were performed. It has been demonstrated that residual LIN was present in the majority of cases after excisional biopsy [24] . This results suggested that the removal of the initial LIN may be beneficial. As previously stated the risk of IBC for the ipsilateral breast was near the level observed for the contralateral breast. However, in most series it was slightly lower ( Table 2 ). This could be in keeping with an evolution of the LIN into IBC in some women. Although not predominant, lobular invasive breast cancer was over represented in IBC recurrences since it was observed in 30% of cases, whereas it only represents 16% of IBC in the general population [1] . Moreover lobular invasive breast cancers were more frequent in the ipsilateral breast (51%) as compared to the contralateral (41%). Finally the M A N U S C R I P T
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In this review LIN patients had a relative risk of IBC that was 2 to 4 folds that of the general population, except in the study of Andersen et al [17] . Since the majority of LIN patients will ultimately not develop an IBC, the identification of subgroups of patients at increased risk would be helpful to tailor the initial treatment. Studies that have attempted to identify IBC risk modifiers in LIN patients have however yielded either inconclusive or conflicting results.
An exception is exemplified by the pathological grading system proposed by Fisher et al [7] , which however requires confirmation in further studies.
Conclusions
This review of the current data on LIN presents strong arguments for LIN both as a precursor and a risk factor for IBC. In the author's opinion, consideration of the precursor argument makes it logical to attempt to remove the LIN. However, the risk factor aspect with a low level of risk and a risk for contralateral breast cancer argue in our opinion for a lumpectomy rather than a mastectomy, and a close follow-up. Further evaluations are required to evaluate the potential benefit of the removal of the LIN, the role of free margins, and to identify IBC risk modifiers among LIN patients.
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-Expression of follow-up*median, §mean, **minimal and maximal follow-up -In the study of Sunshine one patient died from metastases after ipsilateral mastectomy without contralateral breast cancer. Legend: The ratio observed to expected (number of IBC observed in the study group of women with a past history of LIN to the number of IBC expected in this group on the basis of incidence rates in the general population) was expressed either as the Relative Risk (*), the hazard ratio (**) or the Standardized Incidence Ratio ( §), according to the study design.
